Human Papillomavirus Genotyping by the DNA Chip in the Cervical Neoplasia

DNA and Cell Biology

Volumn 23, Issue 2, 2004, Pages 119-125

  Park, Tae Chul ^a   Kim, Chan Joo ^a   Koh, Young Me ^a   Lee, Keun Ho ^a   Yoon, Joo Hee ^a   Kim, Ji Hoon ^a   Namkoong, Sung Eun ^a   Park, Jong Sup ^a,b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER INVASION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DNA DETERMINATION; DNA MICROARRAY; DNA SEQUENCE; FEMALE; GENETICS; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; PAPILLOMA; PAPILLOMA VIRUS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SUPERINFECTION; TUMOR BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIRUS DETECTION; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

FEMALE; GENOTYPE; HUMANS; KOREA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAPILLOMA; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS; PAPOVAVIRIDAE;

EID: 1242337290     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454904322759939     Document Type: Article

References (28)

1. AMERICAN SOCIETY OF CYTOPATHOLOGY (2001). Cervical cancer cytology practice guideline. Acta Cytologica 45, 201-226.
2. BOSCH, F.X., MANOS, M.M., MUNOZ, N., SHERMAN, M.E., JANSEN, A.M., PETO, J., SCHIFFMAN, M.H., MORENO, V., KURMAN, R., and SHAH, K.V. (1995). Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) study Group. J. Natl. Cancer Inst. 87, 796-802.
3. CHAN, P.K.S., LAM, C.W., CHEUNG, T.H., LI, W.W.H., LO, K.W.K., CHAN, M.Y.M., CHEUNG, J.L.K., and CHEUNG A.F. (2002). Association of human papillomavirus type 58 variant with the risk of cervical cancer. J. Natl. Cancer Inst. 94, 1249-1253.
4. CHEN, S.L., HAN, C.P., TSAO, Y.P., LEE, J.W., and YIN, C.S. (1993). Identification and typing of human papillomavirus in cervical cancer in Taiwan. Cancer 78, 1939-1945.
5. CLAVEL, C., MASURE, M., BORY, J.P., PUTAUD, I., MANGEON-JEAN, C., LORENZATO, M., NAZEYROLLAS, P., GABRIEL, R., QUEREUX, C., and BIREMBAUT, P. (2001). Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br. J. Cancer 84, 1616-1623.
6. CUZICK J. (2000). Human papillomavirus testing for primary cervical cancer screening. JAMA 282, 108-109.
7. CUZICK, J., BEVERLEY, E., HO, L., TERRY, G., SAPPER, H., MIELZYNSKA, I., LORINCZ, A., CHAN, W.K., KRAUSZ, T., and SOUTTER, P. (1999). HPV testing in primary screening of older women. Br. J. Cancer 81, 554-558.
8. HILDESHEIM, A., SCHIFFMAN, M.H., GRAVITT, P.E., GLASS, A.G., GREER, C.E., ZHANG, T., SCOTT, D.R., RUSH, B.B., LAWLER, P., and SHERMAN, M.E. (1994). Persistence of type-specific human papillomavirus infection among cytologically normal women. J. Infect. Dis. 169, 235-240.
9. HO, G.Y., BIERMAN, R., BEARDSLEY, L., CHANG, C.J., and BURK, R.D. (1998). Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338, 423-428.
10. KIM, C.J., JEONG, J.K., PARK, T.S., PARK, T.C., NAMKOONG, S.E., and PARK, J.S. (2003). HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions. Gynecol. Oncol. 89, 210-217.
11. KULASINGAM, S.L., HUGHES, J.P., KIVIAT, N.B., MAO, C., WEISS, N.S., KUYPERS, J.M., and KOUTSKY, L.A. (2002). Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: Comparision of sensitivity, specificity, and frequency of referral. JAMA 288, 1749-1757.
12. LORINCZ, A.T. (1996). Hybrid capture method for detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep. 7, 1-5.
13. LORINCZ, A.T., REID, R., JENSEN, A.B., GREENBERG, M.D., LANCASTER, W., and KURMAN, R.J. (1992). Human papillomavirus infection of the cervix: Relative risk association of 5 common anogenital types. Obstet. Gynecol. 79, 328-337.
14. MANDELBLATT, J.S., LAWRENCE, W.F., WOMACK, S.M., JACOBSON, D., Yi, B., HWANG, Y.T., GOLD, K., BARTER, J., and SHAH, K. (2002). Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 287, 2372-2381.
15. MUNOZ, N. (2000). Human papillomavirus and cancer: The epidemiological evidence. J. Clin. Virol. 19, 1-5.
16. MUNOZ, N., BOSCH, F.X., SANJOSE, S., HERRERO, R., CASTELLSAGUE, X., SHAH, K.V., SNIJDERS, P.J.F., MEIJER, C.J.L.M., for the IARC study group. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348, 518-527.
17. NAKAGAWA, S., YOSHIKAWA, H., ONDA, T., KAWANA, T., IWAMOTO, A., and TAKETANI, Y. (1996). Type of human papillomavirus is related to clinical features of cervical carcinomas. Cancer 78, 1935-1941.
18. NATIONAL CANCER INSTITUTE WORKSHOP. (1989). The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnosis. JAMA 262, 931-934.
19. NOBBENHUIS, M., WALBOOMERS, J.M.M., HELMERHORST, T.J.M., ROZENDAAL, L., REMMINK, A.J., RISSE, E.K.J., VAN DER LINDEN, H.C., VOORHORST, F.J., KENEMANS, P., and MEIJER, C.J.H..L.M. (1999). Relation of human papillomavirus to cervical lesions and consequences for cervical cancer screening: A prospective study. Lancet 354, 20-25.
20. REMMINK, A.J., WALBOOMERS, J.M.M., HELMERHORST, T.J.M., VOORHORST, F.J., ROZENDAAL, L., RISSE, E.J., MEIJER, C.J.L.M., and KENEMANS, P. (1995). The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months. Int. J. Cancer 61, 306-311.
21. SASAGAWA, T., BASHA, W., YAMAZAKI, H., and INOUE, M. (2001). High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol. Biomarkers Prev. 10, 45-52.
22. SASLOW, D., RUNOWICZ, C.D., SOLOMON, D., MOSCICKI, A.B., SMITH, R.A., EYRE, H.J., and COHEN, C. (2002). American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J. Clin. 52, 342-362.
23. SCHIFFMAN, M.H., BAUER, H.M., GLASS, A.G., CADELL, D.M., RUSH, B.B., SCOTT, D.R., SHERMAN, M.E., KURMAN, R.J., WACHOLDER, S., STANTON, C.K., et al. (1993). Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85, 958-964.
24. SCHIFFMAN, M.H., HERRERO, R., HILDESHEIM, A., SHERMAN, M.E., BRATT, M., WACHOLDER, S., ALFARO, M., HUTCHINSON, M., MORALES, J., GREENBERG, M.D., and et al. (2000). HPV testing in cervical cancer screening; Results from women in a high-risk province of Cost Rica. JAMA 283, 87-89.
25. SHLAY, J.C., DUNN, T., BYERS, T., BARON, A.E., and DOUGLAS, J.M., JR. (2000). Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears. Obstet. Gynecol. 96, 410-416.
26. SOLOMON, D., SCHIFFMAN, M., TARONE, R., and ALTS Study group. (2001). Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J. Natl. Cancer Inst. 93, 293-299.
27. THE ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE/LOW-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS TRIAGE STUDY (ALTS) GROUP. (2000). Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial. J. Natl. Cancer Inst. 92, 397-402.
28. WRIGHT, T.C., and SCHIFFMAN, M. (2003). Adding a test for human papillomavirus DNA to cervical cancer screening. N. Engl. J. Med. 348, 489-490.